| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-16 |
| filingDate |
2002-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56b4281e226bb41920845e1054e0ff95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45f8d5bfd3bdbd8dfb16613c1a388442
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3240f52f5e95f67b21e3179adefefa89 |
| publicationDate |
2003-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6596760-B1 |
| titleOfInvention |
Antidiabetic 4-hydroxy-2-furoic acids |
| abstract |
Substituted 4-hydroxy-2-furoic acids are obtained by the fermentation of an asterriquinone, which is a natural product having a 2,5-dioxy-3,6-bis(indolyl)quinone structure. The compounds modulate insulin receptor tyrosine kinase activity and may be useful in the treatment of diabetes and other diseases or conditions characterized by impaired endogenous insulin production or an impaired response to endogenous insulin. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7834050-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9890187-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007232663-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006122232-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10640524-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8222279-B2 |
| priorityDate |
2001-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |